Your browser doesn't support javascript.
loading
Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure-Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis.
Zhang, Xiaoping; Goel, Varun; Attarwala, Husain; Sweetser, Marianne T; Clausen, Valerie A; Robbie, Gabriel J.
Affiliation
  • Zhang X; Alnylam Pharmaceuticals, Cambridge, MA, USA.
  • Goel V; Alnylam Pharmaceuticals, Cambridge, MA, USA.
  • Attarwala H; Alnylam Pharmaceuticals, Cambridge, MA, USA.
  • Sweetser MT; Alnylam Pharmaceuticals, Cambridge, MA, USA.
  • Clausen VA; Alnylam Pharmaceuticals, Cambridge, MA, USA.
  • Robbie GJ; Alnylam Pharmaceuticals, Cambridge, MA, USA.
J Clin Pharmacol ; 60(1): 37-49, 2020 01.
Article in En | MEDLINE | ID: mdl-31322739

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prealbumin / Amyloid Neuropathies, Familial / RNA, Small Interfering Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2020 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prealbumin / Amyloid Neuropathies, Familial / RNA, Small Interfering Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2020 Document type: Article Affiliation country: United States